Abstract: Approximately 50% of the forearm vasodilatation to intra-arterial infusions of acetylcholine is mediated by endothelium-derived nitric oxide. These conclusions have been derived from venous occlusion plethysmographic measurements of total forearm blood flow during coinfusions of acetylcholine and fIIG-monomethyl-L-arginine (L-NMMAl. an inhibitor of nitric oxide synthase. Since venous occlusion plethysmography measures total limb blood flow, the relative proportion of the measurement from skin cannot be determined precisely. To determine the effects of acetylcholine on skin specifically, we have used laser Doppler flowmetry to measure vascular responses to local iontophoresis of acetylcholine in the forearm of normal male volunteers. To elucidate the possible mechanisms of cutaneous vasodilatation to acetylcholine, vascular responses were measured before and after systemic inhibition of prostanoid production and nitric oxide synthesis by oral aspirin (600 mg daily for 3 days) and intravenous L-NMMA (3 mg/kg for 60 min), respectively. After aspirin administration, dose-dependent vascular responses to acetylcholine were reduced significantly by approximately 53% (p<0.005, ANOVA). In contrast, intravenous L-NMMA appeared to have no significant effect on cutaneous vascular responses to acetylcholine. While the role of nitric oxide is uncertain, vasodilatation to acetylcholine in the forearm skin is mediated largely by a prostanoid-dependent mechanism. Assessment of cutaneous vascular responses to iontophoresis of acetylcholine may, therefore, be useful in diseases where abnormal endothelium-dependent prostanoid function has been implicated.
Introduction
In 1980, Furchgott and Zawadzki showed that the vascular properties of acetylcholine are dependent on the presence of an intact endothelium. I Abnormal vascular responses to acetylcholine, in the face of normal vasodilator responses to endothelium-independent vasodilators that donate nitric oxide (NO), are thought to reflect endothelial cell dysfunction in the L-arginine/NO pathway. The extent of endothelial dysfunction is often inferred from assessing forearm vascular responses during intra-arterial infusions of acetylcholine, while measuring subsequent changes in total limb blood flow by venous occlusion plethysmography. Using this technique, approximately 50% of the vascular relaxation to acetylcholine has been shown to be mediated by release of endothelium-derived NO as shown by the inhibitory effect of NJ-monomethyl-L-arginine (L-NMMA), an inhibitor of NO synthase.i While some vasodilatation to acetylcholine may be via the release of endotheliumderived hyperpolarizing factor;' prostanoids are thought to playa negligible role."
Venous occlusion plethysmography measures total limb blood flow and does not allow separation of blood flow through muscle and skin. Considering their different functions. it is possible that vascular reactivity differs between © Arnold 1997 these vascular beds. Indeed. Khan et al showed recently that L-NMMA has no effect on forearm cutaneous vasodilatation. as measured by laser Doppler flowmetry, during co-infusion of methacholine, a stable analogue of acetylcholine." Simultaneous measurements of total forearm blood flow by venous occlusion plethysmography, however, showed that L-NMMA reduces the vasodilator response to methacholine significantly.
We hypothesized that while NO may playa significant role in the forearm muscle response to acetylcholine. its effect on skin blood vessels may be mediated differently. possibly by prostanoids. In the present study. therefore, we have used laser Doppler flowrnetry to measure cutaneous vascular responses to iontophoresis of acetylcholine in forearm skin. To elucidate whether prostanoids are involved. we measured cutaneous vascular responses to acetylcholine before and after oral administration of aspirin. The possible contribution from NO was determined before and after systemic inhibition of NO synthesis by intravenous L-NMMA.
Methods
Twenty-five healthy male volunteers (age range 22-41 years) were recruited for this study. which was approved by the local Ethics Committee. All subjects gave informed consent. No subject had taken any nonsteroidal antiinflammatory medication for 7 days before the study. except for aspirin as part of the study. Subjects refrained from smoking from the night before the study and food and caffeine-containing beverages were not consumed for at least two hours before the tests. All experiments were performed in the morning.
Iontophoresis and measurement of skin erythrocyte flux
Skin erythrocyte flux was measured continuously at the volar surface of the forearm using a laser Doppler flowmeter (MBF3/D, Moor Instruments, Axrninster, UK). Cutaneous vascular responses were measured during iontophoretic application of acetylcholine. Iontophoresis provides a convenient method for producing a quantifiable stimulus to the microvasculature and can be used effectively to transport drugs in solution across intact skin." The technology is based on the principle that an electrical potential difference will cause ions in solution to migrate according to their electrical charge. To transfer a drug into the skin, the polarity of the active electrode has to have the same charge as the active ions of the drug. For a given drug, the quantity delivered is directly proportional to the total charge that migrates through the skin surface. The total charge can be increased by increasing either the current or the time.
Experiments were conducted in a room temperature set at 22-23°C with subjects lying in the supine position. Subjects were given a 30-min equilibration period. The skin of the right volar forearm was cleaned gently with alcohol and a direct electrode chamber was attached using double-sided adhesive tape to a site of unbroken skin, approximately midway between the wrist and elbow. The site of iontophoresis was marked with an indelible marker and subjects were requested to maintain the markings to enable the electrode chamber to be placed at the same site between visits. The electrode chamber was 8 mm in height and had an outer diameter of 30 mm and a central hole (3.5 mm diameter) that kept the laser probe in position. Around the central hole was an inner chamber (8 mm diameter) into which solutions (approximately 0.5 m!) were applied for iontophoresing at the test site. An additional probe holder was attached 2 ern distal to the test area and served as a control site. The indifferent electrode was a Velcro strap that was soaked in deionized, sterile water and placed around the subject's right wrist to complete the circuit. The leads from the direct electrode chamber and the indifferent electrode were connected to a battery-powered iontophoresis controller (MIC I, Moor Instruments, Axminster, UK), which provided a direct current for the delivery of solutions.
Effects of current on skin erythrocyte flux
In eight subjects, the effect of current alone on skin erythrocyte flux was examined. Deionized, sterile water was placed into the inner drug chamber and iontophoresed using an anodal Current of 0.2 rnA for 10, 20 and 40 s, giving charges of 2, 4 and 8 milli Coulombs (mC), respectively. Skin erythrocyte flux was measured continuously during the period of iontophoresis and subsequent vascular responses were measured for 4 min.
Effects of aspirin and L·NMMA on cutaneous vascular responses to acetylcholine
Fifteen subjects were used to examine the effects of aspirin on cutaneous vascular responses to acetylcholine. Subjects were studied on two different occasions, at least 10 days
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Cutaneous vasodilatation to acetylcholine 83 apart. One visit was used for measurement of vascular responses to acetylcholine under control conditions (i.e. without aspirin), and on the other occasion, vascular responses were measured after oral administration of enteric coated aspirin (600 mg/day, Nu-Seal 300, Eli Lilly, Basingstoke, UK) for 3 days. The order of visits was randomized. Cutaneous vascular responses were measured approximately 2 h after the last dose of aspirin.
Acetylcholine chloride (Sigma Chemical, St Louis, MO, USA) was made up to a I% solution in deionized, sterile water and iontophoresed for lOs using a 0.2 mA anodal current (charge = 2 mC). To increase the dose, acetylcholine was iontophoresed for 20 and 40 s (i.e. 4 mC and 8 mC charge), with skin erythrocyte flux being recorded for 4 min between each dose.
On another occasion in 10 subjects who did not participate in the aspirin studies, the left antecubital vein was cannulated under local anaesthetic for infusion of 0.9% saline or L-NMMA (Clinalfa AG, Switzerland). After at least 25 minutes of equilibration, subjects received either placebo (0.9% saline) or L-NMMA intravenously in a randomized, cross-over manner that was blind to the subject. The infusions were reversed at least one week later. For L-NMMA, a 1.5 mg/kg bolus was infused initially for 5 min followed by a 3 mg/kg dose for 60 min. After 15 min of infusion, acetylcholine was iontophoresed on the contralateral forearm as described above. Blood pressure and heart rate were measured automatically at the upper arm (Dinamap, Critikon Inc., Tampa, FL, USA) at 3-min intervals throughout the infusions.
Statistical analysis
Results are expressed as means ± SEM. Skin erythrocyte flux is expressed in arbitrary units (AU). The area under the curve (AUC) was calculated for a 4-min basal period and for each 4-min period following iontophoresis of deionized water and acetylcholine. The response to each dose was expressed as the difference between the AUC after iontophoresis and basal AUe. The effect of current on skin erythrocyte flux was analysed using one-way analysis of variance. Differences in the AUe for acetylcholine before and after aspirin and L-NMMA were tested using two-way analysis of variance for repeated measures, followed by {-tests (after Bonferroni corrections for mulliple testing) at each dose when a significant difference was found. Differences in blood pressure and heart rate between L-NMMA and placebo visits were assessed using the paired t-test. The null hypothesis was rejected at p<0.05. Statistical analyses were performed using the SPSS software (SPSS Inc., I1i-nois, USA).
Results
Effects of current on skin erythrocyte flux Iontophoresis of deionized water using an anodal current had no significant effect on skin erythrocyte flux. Baseline skin erythrocyte flux was 3.1 ± 0.1 AU and after 2, 4 and 8 me was 1.6 ± 1.4,4.5 ± 2.1 and 12.9 ± 5.1 AU, respectively. Since the anodal current showed a small, but not significant, nonspecific effect on skin erythrocyte flux at 8 mC, the effects of L-NMMA and aspirin on cutaneous vascular responses to acetylcholine were compared at 2 mC and 35 Effects of L-NMMA on blood pressure and heart rate !a?l~I shows the effects of L-NMMA against placebo infusion on blood pressure and heart rate. Baseline values for blood pressure and heart rate were similar for placebo and L-N~~~infu.sion days. Intravenous L-NMMA produced a significant increase in mean arterial hlood pressure (MAP) (p<0.05) and a significant decrease in heart rate (p<0.05) that was significantly different from the response to placebo (p<O.05 for hoth). Over the period of infusion, MAP increased by an average of 4% (82 ± 2 to 85 i: 2 mmHg) and heart rate decreased by 7% (57 ± 2 to 53 ± 3 beats/minute).
r~s'pective!t In contrast. infusion of L-NMMA had no signiticant effect on the cutaneous vascular responses to acetylcholine ( Figure 2) . Based on the above results of an average 53% .d~crease in skin vasodilatation to acetylcholinẽ lfter aS~lfln. administration. the number of subjects included 1/1 this study (i.e. 15) were sufficient to detect a true effect of aspirin with a power of 80% at a significance level of 5%, which is within the recommended range." The main new finding from the present study is that local iontophoresis of acetylcholine to forearm skin produces vasodila~ation by a. mechanism that is dependent largely on prostanoid production, Of the known effects of aspirin, it is mo~t.likely that the significant inhibitory effect of systemic aspmn was due to inhibition of the cycle-oxygenase pathway. It would appear that NO does not contribute to basal blood flow or acetylcholine-induced vasodilatation in the skin. However, there is some uncertainty regarding the role of NO because although intravenous L-NMMA had no significant effect on cutaneous vascular responses, we cannot be completely certain that L-NMMA reached the cutaneous micr.ovessels in a concentration sufficient to inhibit NO production. Some vasodilatation may be from other factors, such as endothelium-derived hyperpolarizing factor," since aspirin did not inhibit the response to acetylcholine completely. Recently, evidence has been provided to show that local generation of dilator prostanoids predominate and alter vascular tone in human superficial hand veins." Bhagat et al showed that locally infused arachidonic acid causes dosedependent venodilatation that is inhibited for up to 5 days by systemic aspirin (l g orally).H In forearm skin, bradykinin-induced vasodilatation is also reduced by the cyclooxygenase inhibitor indomethacin," further supporting the role of prostanoids in cutaneous blood vessels. It is unlikely that the observed inhibitory effect of aspirin in our study was due to its effect on platelets. Low dose aspirin (75 mg) has been shown to inhibit platelet aggregation but have no effect on arachidonic acid induced venodilatation."
The findings from our study are in contrast to those from a study by Warren" who showed that the local vasodilatation to intradermal injection of acetylcholine is inhibited by co-injection with L-NMMA but not indomethacin. The reasons for this difference are not clear but may be related to the method of drug delivery. Although effort was taken to minimize the effect of trauma induced by the injection in the study by Warren," some attenuation of the response to acetylcholine by L-NMMA may have resulted from inhibition of the inflammation induced by the injection. We avoided the potential effects of needle trauma by using the noninvasive technique of iontophoresis to deliver the drugs across the skin. Warren did conclude, however, that on a molar basis, prostanoids exerted a greater influence on skin rnicrovessels than endogenous NO. 9 Relatively little information is available regarding the role of NO in the control of the cutaneous microcirculation in humans. In animals, NO has been shown to be involved in the basal control of skin blood flow by maintaining vasodilator tone that counteracts vasoconstrictor activity. 10 .1 1 In humans, however, the role of NO in regulating cutaneous vascular tone is controversial. NO has been shown to contribute to the basal dilator tone in the dorsal finger and forearm skin,'.12 which is in contrast to the findings of Noon et al!' who showed that NO has no effect on resting vascular tone in the dorsal surface of the finger, but does in the pulp where thermoregulatory arteriovenous anastomoses are present. The current study supports the idea that basal release of NO is not important in the regulation of skin blood flow. A major function of the cutaneous circulation is maintenance of body temperature, but NO appears to playa relatively minor role during reflex sympathetic vasoconstriction 12 and in the cutaneous vasodilatation during body heating.l'v!" The idea that NO may play only a minor role in the human cutaneous microcirculation is consistent with previous observations that sodium nitroprusside, which donates NO, has a relatively small effect on skin blood flow. I' It is possible that the reason for observing no change in basal skin erythrocyte flux or acetylcholine-induced vasodilatation is that an insufficient concentration of L-NMMA was delivered intravenously. We think that this is unlikely for the following reasons. The dose of L-NMMA used in the present study did produce a systemic effect as observed by the small increase in MAP, presumably due to a direct effect of inhibition of endothelial NO synthase, and a decrease in heart rate, the latter being due most likely to a reflex response to the increase in blood pressure. It is unlikely that the increase in MAP was sufficient to mask a decrease in skin erythrocyte flux during L-NMMA infusion. We saw no change in basal skin erythrocyte flux after infusion of L-NMMA for 15 min, a time at which the effect on peripheral resistance is maximal." Using the same dose of L-NMMA as in the present study, Haynes et al reported a 46% increase in calculated total peripheral resistance. 16 They stated that a 3 mg/kg dose of L-NMMA would achieve a blood L-NMMA concentration of approximately Vascular Medicine 1997; 2: 82-86 40 I-lg/ml, which is similar to the concentration of 20 u.g/ml achieved in brachial artery studies where total forearm blood flow responses to acetylcholine arc reduced. A 3 mg/kg dose of L-NMMA is sufficient to reduce plasma nitrite concentrations significantly, which reflect NO production.!? Intra-arterial infusions of L-NMMA have been shown to have no effect on basal skin erythrocyte flux and skin temperature at the dorsal surface of the hand, 1.1 Furthermore, in support of our arguernent that acetylcholineinduced vasodilatation is not mediated by NO, Khan et al have shown that intra-arterial L-NMMA (8 f-LM/min) does not alter vasodilatation to methacholine.'
In conclusion, we have shown that aspirin inhibits the vascular response to acetylcholine in human forearm skin. While the role of NO remains controversial, it is clear from this study that vasodilatation to acetylcholine in the forearm skin is mediated largely by a prostanoid-dependent mechanism. These findings highlight a major difference between skin and muscle blood vessels in their response to acetylcholine. Iontophoresis of acetylcholine may be useful, therefore, in conditions such as hypertension and diabetes mellitus where altered endothelium-dependent prostanoid function has been implicated.
